ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 104 filers reported holding ENDOLOGIX INC in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $610,000 | +317.8% | 851,479 | +1017.7% | 0.00% | – |
| Q3 2018 | $146,000 | -91.9% | 76,181 | -76.2% | 0.00% | -100.0% |
| Q2 2018 | $1,812,000 | +21.8% | 319,978 | -9.1% | 0.00% | 0.0% |
| Q1 2018 | $1,488,000 | +280.6% | 351,899 | +300.8% | 0.00% | – |
| Q3 2017 | $391,000 | -84.5% | 87,809 | -74.8% | 0.00% | -100.0% |
| Q1 2017 | $2,523,000 | +157.4% | 348,460 | +103.4% | 0.00% | +100.0% |
| Q4 2016 | $980,000 | +1039.5% | 171,333 | +1572.4% | 0.00% | – |
| Q1 2016 | $86,000 | -15.7% | 10,245 | -0.4% | 0.00% | – |
| Q4 2015 | $102,000 | -99.1% | 10,288 | -98.8% | 0.00% | -100.0% |
| Q3 2015 | $10,953,000 | +6305.3% | 893,413 | +7904.1% | 0.01% | – |
| Q2 2015 | $171,000 | -32.9% | 11,162 | -25.3% | 0.00% | – |
| Q1 2015 | $255,000 | -56.4% | 14,933 | -61.0% | 0.00% | -100.0% |
| Q4 2014 | $585,000 | -96.1% | 38,259 | -97.3% | 0.00% | -93.8% |
| Q3 2014 | $15,058,000 | +6.9% | 1,420,568 | +53.4% | 0.02% | 0.0% |
| Q2 2014 | $14,081,000 | +2307.0% | 925,760 | +2661.2% | 0.02% | +1500.0% |
| Q4 2013 | $585,000 | -14.5% | 33,528 | -21.0% | 0.00% | 0.0% |
| Q3 2013 | $684,000 | -54.1% | 42,415 | -62.2% | 0.00% | -66.7% |
| Q2 2013 | $1,491,000 | – | 112,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|